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ABSTRACT 
 
Placental abruption is one of the causes of   obstetric haemorrhage that is associated with 
adverse maternal and neonatal outcomes. Knowledge of the risk factors and complications of 
placental abruption is important to reduce the maternal and perinatal morbidity and mortality 
associated with this condition. 
Objectives 
 
1. To determine the frequency of abruptio placentae at Chris Hani Baragwanath 
Academic Hospital. 
2. To assess maternal risk factors common in the patients admitted with placental 
abruption. 
3. To determine the number of patients that had operative deliveries. 
4. To assess maternal morbidity associated with placental abruption. 
5. To assess perinatal outcomes of births in women with abruptio placentae. 
Methods  
This was a descriptive prospective study of morbidity in women with placental abruption. The 
study was carried out in the department of Obstetrics and Gynaecology at Chris Hani 
Baragwanath Hospital (CHBAH). Patients with placental abruption who gave informed 
consent to participate in the study were interviewed using a structured questionnaire. The 
study was conducted at Chris Hani Baragwanath Hospital. The study was carried out over a 6 
month period and 60 subjects were recruited. All the women with the diagnoses of placental 
abruption and singleton pregnancies were included in the study.  
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Results  
Of the 13734 delivered women 60 patients (0.4%) had placental abruption. Out of the 60 
patients 53 (83%) were booked. The age group was between 18 – 42 years with the mean age 
of 28.2±6.8years. The mean gestational age on admission was 31.8±4.7. 
Forty six (71.6%) patients had parity of one and more. The risk factors that were identified in 
the study were previous history of placental abruption which occurred in 4 patients 
(6.7%),previous caesarean section in 7 (11.7%).The commonest medical disorder observed 
was hypertensive disease, pre-eclampsia was found in 24 patients(40%), gestational 
hypertension was found in 5 patients (8.3%) and chronic hypertension in 4(6.7%). 
The maternal complications that were identified were PPH in 15(44%) patients that had 
stillbirths compared to  1(3.8%) in the group that had live births, DIC was observed in 8 
(23.5%),haemorrhagic shock occurred in 2 (5.9%) of the patients, acute kidney injury in 
20(58.8%) in the group that had stillbirths compared to 3(11.5%) in the group that had live 
births, Couvelaire uterus in  9(26.4%) in the group that had still births, hysterectomy was 
performed in 2 (5.8%) and ICU admission was required for 5 (14.7%) of the patients. 
The neonatal out comes that were observed were stillbirths in 34 patients, birth asphyxia in 
5(19.2%) and ICU admission was required in 11(42.3%). There were no maternal deaths. 
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Conclusion  
In conclusion placental abruption is still a dangerous complication for both the mother and 
baby. In this study the patients that had stillbirths had worse outcomes compared to those that 
had live births.  Therefore the conditions that are associated with this condition should be 
identified. Early recognition of this condition as well as proper referral of the patient can 
ensure better outcomes.    
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1. INTRODUCTION 
Abruptio placenta is a serious obstetric condition that increases both maternal and neonatal 
morbidity and mortality (1).It is a major cause of ante partum haemorrhage accounting for 
22% of ante partum haemorrhage (2). 
Placental abruption is defined as the premature separation of a normally situated placenta 
from the uterine wall before the baby is delivered (3).  The exact gestation from which an 
abruption can be diagnosed varies in the literature from 20 weeks to 24 weeks (3, 4). Current 
studies show that it occurs in 0.5 to 1% of pregnancies (5, 6). The incidence world -wide has 
increased between the years 1998-2008 from 0.6 to 0.8% (5). Placental abruption rates tend to 
vary with gestational age with preterm gestations having a higher rate of about 5.4% and as 
pregnancy advances towards term the rate declines to around 0.3% (5). The incidence is 
highest between 24 to 26 weeks (7).  The maternal mortality rate from placental abruption has 
been quoted to be 1% (3). There were 37 maternal deaths at the Chris Hani Baragwanath 
hospital in 2011 but none were related to or as a direct result of abruptio placentae. 
Placental abruption is an independent risk factor for perinatal mortality (5).  The perinatal 
mortality has been estimated to be as high as 64% (8). In a cross-sectional study of 50 patients 
with abruptio placentae by Tulpur et al which was conducted in Jinnah Post graduate Medical  
Centre  Karachi in 2011, 18 (36%) babies were born alive, 25(50%) were stillbirths and early 
neonatal deaths occurred in 14% (8).  
Abruptio   placenta is a clinical diagnosis and the diagnostic value of ultrasound has been 
shown to be weak (9).  However, with posterior positioned placentae, the presentation may be 
atypical and complicate the diagnosis. The commonest clinical feature is a retro-placental clot 
or retro-placental bleeding and the incidence is observed to be as high as 77.1% (9).  
This indicates that a substantial percentage of patients may have concealed abruptios. 
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A concealed abruptio is said to be present when blood is retained behind the placenta and its 
margins are still adherent and a revealed abruptio occurs when external haemorrhage is 
observed after the escaping blood dissects through the fetal membranes from the uterine wall. 
Other diagnostic features include vaginal bleeding with uterine hyper-tonicity and vaginal 
bleeding with non-reassuring fetal non-stress tests (9). 
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2. LITERATURE REVIEW 
2.1 Causes and risk factors 
The exact cause of placental abruption remains unclear even after extensive research (4, 5). 
However, several risk factors have been identified that predispose a pregnant woman to this 
condition. The risk factors may be categorized into medical, social and obstetric risk factors 
(10) .Risk factors may also be classified into potentially preventable factors such as smoking 
and cocaine use and non- preventable such as trauma (10). 
2.1.1 Antenatal care and risk categorization 
Bibi et al  conducted a study in 2009  in Liaquat  University Hospital Hyderabad and 
identified the lack of antenatal care, and rural residence to be important risk factors in women 
who develop abruptio placentae, as attendance at antenatal clinic may  provide important 
information such as iron and folate deficiency(4).                                                                                                                                         
Also pre-existing conditions such as hypertension and diabetes can be treated if patients are 
assessed frequently in their pregnancies (4). In a retrospective analysis of risk factors and 
clinical outcomes of placental abruption by Bibi et al, anemia was identified as one of the risk 
factors that predisposes to the development of haemorrhage and its complications and the 
incidence was observed to be as high as 79%, but there was no conclusive evidence whether 
the anemia was the cause or as result of placental abruption itself (4). 
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2.1.2 Hypertensive disease 
Hypertension is described as being the systolic blood pressure that is equal to 140 mmHg and 
diastolic blood pressure equal to 90 mmHg taken at least on two occasions at least 4 hours 
apart (11). 
Pre-eclampsia, (defined as hypertension accompanied by proteinuria diagnosed after 20 weeks 
of gestation) which complicates 5-7% of pregnancies, has also been identified as a risk factor 
(12).  Evidence has shown that placental abruption occurs in 1.5% of pregnant women with 
pre-eclampsia and that its frequency is not affected by duration of the hypertension and 
presence or absence of proteinuria (12). Ananth et al reported that the incidence of abruption 
was greatest among women whose pregnancies were complicated by severe pre-eclampsia 
and the incidence in that study was found to be 3.73 % (13). In comparison normotensive 
women were found to have risk of 0.92 % (13). In contrast women that had mild pre-
eclampsia had no increased risk of placental abruption (13).  Leunen et al conducted a study 
in 2003 in a tertiary referral center in South Africa, the study looked at the profiles and 
complications of women with placental abruption and intrauterine deaths in 96 women. 
Seventy-five percent of patients with placental abruption had hypertensive disorders and 
severe pre-eclampsia accounted for 44.8% of the 96 women. Smokers with severe pre-
eclampsia are also more likely to develop placental abruption (14). 
Chronic hypertension with superimposed pre-eclampsia has been shown to be a risk factor for 
placental abruption in other studies (12).Chronic hypertension is described as being high 
blood pressure that is diagnosed before 20 weeks or if women are already taking 
antihypertensive treatment when referred to maternity services (7).Ananth et al found that 
chronic hypertension complicates 0. 3-0. 8% of pregnancies and that advanced maternal age, 
parity, cigarette smoking and black race increase the risk (15).No association has been shown 
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between chronic hypertension and placental abruption, but chronic hypertension with 
superimposed pre-eclampsia is associated  with placental abruption with an incidence of 
5,2%(15).  
Studies have shown that women with chronic hypertension with superimposed pre-eclampsia 
have a 2.8 to 7.7 fold increased risk for placental abruption (15).  
The mechanism by which hypertensive disease leads to placental abruption is as follows: 
It is postulated that during normal pregnancy the spiral arteries undergo transformation from 
being muscular arterioles to low resistance dilated vessels (14). These changes occur as a 
result of trophoblastic invasion which occurs between 10-20 weeks. In pregnancies that are 
complicated by hypertensive disorders there is absence of such changes. The lack of 
trophoblastic invasion results in decreased placental blood flow and dysfunctional   
endothelial responses. Basically these abnormal placental vessels may predispose to ischemia 
and the involved vessels can rupture and thus causing placental abruption. (14). 
2.1.3 Trauma 
Trauma may be blunt or penetrating. Blunt trauma such motor vehicle accidents are a risk 
factor for placental abruption (16). Approximately 6% of trauma cases are associated with 
placental abruption but if the trauma is major the incidence could increase to 20-25% (16).   
It is difficult to predict the risk of placental abruption based on the severity of the trauma. 
Placental abruption usually manifests within 6-48 hours following the trauma but can occur 
up to 5 days later (16).It is recommended that these patients get admitted. The initial efforts 
are directed at evaluating and stabilizing the maternal vital signs. During the assessment 
primary and secondary surveys are done. Primary survey is done so as to make sure that   
breathing is adequate, airway is secure and that there is adequate circulation in those that are 
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seriously injured. The secondary survey involves the examination of all the body regions and 
it also includes fetal evaluation. It is recommended that women involved in trauma should 
have 4 hours of fetal monitoring but this duration can be extended if uterine contractions start 
or if the uterus becomes irritable and fetal non-stress tests are non-reassuring. If there is no 
uterine irritability or tenderness, or rupture of membranes the patient may be discharged. 
Upon discharge   strict instructions should be given, the patient should be instructed that if 
there is bleeding, leakage of liquor, decreased fetal movements and severe abdominal pains 
that she must return to the hospital. 
2.1.4 Polyhydramnios 
Polyhydramnios has been described as a risk factor for placental abruption (3). 
Polyhydramnios is defined as the largest vertical pool of amniotic fluid of 8cm or amniotic 
fluid index above the 95th centile for gestational age (17). The theory to support this factor is 
the sudden decompression of the uterus following the rapid loss of amniotic fluid after the 
rupture of membranes. It is the sudden change in the uterine size that predisposes patients 
with Polyhydramnios to placental abruption (3).  
2.1.5 Previous history of placental abruption  
Another important risk factor is a history of a previous abruption.  After one episode the 
recurrence rate is 11% and increases to 25% after two episodes (3). Since these women are at 
risk of repeat placental abruption, there are recommendations by Oyelese et al on managing 
subsequent pregnancies. The recommendations are that, the women with identifiable risk 
factors should be thoroughly counseled (18). If the woman is a smoker she should be advised 
to stop smoking   before the next pregnancy. According to literature there hasn’t   been any 
intervention that has reduced the recurrence of placental abruption, since this condition is not   
predictable.  There is also no accurate marker that can predict the recurrence of placental 
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abruption. Another recommendation is that women with a history of placental abruption 
should have serial growth scan every 4 weeks during the second half of pregnancy as they 
have an increased risk of impaired utero-placental perfusion (18). Women with prior history 
of placental abruption can be offered amniocentesis for lung maturity and delivery should be 
aimed at 37 weeks (18). 
2.1.6 Cigarette smoking and cocaine use 
The relative risk of placental abruption varies from 1. 5- 2.5 in women who smoke (19). The 
risk is doubled if both partners are smokers. Tikannen et al conducted a study in 2009 on the 
epidemiology, risk factors and consequences of placental abruption in the university central 
hospital in Finland and found that the risk of placental abruption was 4, 8 fold higher if both 
partners were smokers (10). Paternal smoking as a risk factor could be explained by passive 
exposure of the pregnant woman (20). Several studies suggest that smoking as a risk factor is 
dose dependent (19). Raimond et al found that with every 10 cigarettes smoked each day there 
is a 20% increase in the risk of placental abruption (21). 
The risk of placental abruption is increased by 40% for each year of smoking prior to 
pregnancy (2). 
If smoking has been stopped before pregnancy or early in pregnancy, the risk of abruption can 
be reduced to the level of non –smokers (19).Studies show that if women stopped smoking 
during pregnancy, 15-25% of placental abruption could be prevented (19). 
The assumed mechanism explaining the association of smoking and placental abruption is as 
follows: 
Nicotine in tobacco smoke crosses the placenta leading to higher concentrations in the fetal 
plasma (22). It also concentrates in the placental tissue, amniotic fluid and breast milk. 
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Tobacco causes vasoconstriction in the uterine artery as well as the umbilical artery. These 
changes reduce utero-placental blood flow (22). The risk of placental abruption is six times 
higher in women who smoke and have severe pre-eclampsia compared to women who are 
non-smokers with pre-eclampsia. This is explained by the fact that smoking has vaso-
constrictive effects and so it affects the fragile vessels already compromised by hypertension.  
2.1.7 Cocaine abuse 
The risk of placental abruption in patients that abuse cocaine is also dose dependent, the risk 
is said to be 13-35%.  Cocaine has a vasoconstrictive effect and therefore, interferes with 
utero-placental blood flow and affects the integrity of the decidua (3).  
2.1.8 Previous caesarian section  
Studies show that caesarian section delivery in the first pregnancy increases the risk of 
placental abruption by 30-40% in the next pregnancy (23). If the interval between pregnancies 
is less than one year, the risk of placental abruption is 52% in women that are delivering for 
the first time by normal vaginal route compared to women that are delivering for the first time 
by caesarean section whose risk increases to 111% (24). 
Previous caesarean section scars result in pathological changes in the myometrium and 
endometrium. These changes may cause sub-optimal implantation of the placenta (24). 
2.1.9 Multiparity and advanced maternal age 
Tulpur et al identified Multiparity and advanced maternal age as additional risk factors for 
placental abruption (8).The incidence of placental abruption was higher in women less than 
25 years when compared to women between 25 to 29 years in a study by Ananth et al (25). 
There was no increase in the incidence with advancing maternal age. In contrast, the 
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incidence of placental abruption increased with increasing parity and this was found in 
women that were having their third pregnancy (25). Tikannen et al found that placental 
abruption in women 35 years or older was attributed to high parity irrespective of gestational 
age (21). Sarwar et al conducted a study on placental abruption and its complications between 
July 2003 and June 2004 in Ayub teaching hospital Abbottabad and reported significantly 
higher incidence in the multiparous patients compared to primigravida patients (88.7% vs 11. 
3%) (27). In this study multiparity was supported as a risk factor (26).  
2.1.10 Premature rupture of membranes and chorioamnionitis 
It is suggested that 4-12% of patients with premature rupture of membranes before 37 weeks 
gestation develop placental abruption (27). Placental abruption risk increases with decreasing 
gestational age at membrane rupture. Ananth et al found that preterm labour and pre-labour 
rupture of membranes represent an acute disease process that is associated with placental 
abruption.  Studies have found the incidence of placental abruption to be 4.8% in women that 
had intrauterine infection, in contrast to 0.8% in women that had no intrauterine infection 
(28). 
A sudden reduction in the uterine volume following the rupture of membranes is the 
suspected mechanism that leads to placental abruption (3). The risk of placental abruption is 
also increased by prolonged exposure to premature rupture of membranes and if time from 
membrane rupture to delivery exceeds 24hours (28). The possible   mechanism   involved in 
intra-uterine infections is that, there is direct bacterial colonization of the decidua with tissue 
inflammation which may lead to placental abruption or the infection activates cytokines such 
as IL and TNF and these cytokines up regulate the production and activity of 
metametalloproteases( MMP’S) in the trophoblast, resulting in the destruction of the matrix 
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and cell interactions which may lead to disruption of placental attachment and finally to 
placental abruption.       
Other Miscellaneous risk factors for abruption include poor nutritional status, preterm labour, 
infertility treatment and dietary deficiencies such as folate deficiency and 
hyperhomocysteinemia. There is also an association between thrombophilia and placental 
abruption (3).  
Women with placenta praevia have a 5% chance of having an abruption (20).Other pregnancy 
related risk factors that may predispose to placental abruption include bleeding during 
pregnancy and multiple-pregnancy. Bleeding in the early trimesters,   referring to the bleeding 
that occurs in the first two trimesters of pregnancy has also been associated with placental 
abruption later in pregnancy (20). If a retro-placental clot is detected in the first trimester by 
ultrasound this also increases the risk of placental abruption as the haematoma may interfere 
with normal placentation (29).        
2.2 CLINICAL PRESENTATION 
Abruptio placenta may be graded according to clinical presentation. The following is 
recommended by Sinha et al from the journal of obstetrics and gynaecology 2008 (2). 
Grade 1: Asymptomatic (small retro-placental clot discovered after delivery) 
Grade 2: There is usually vaginal bleeding with uterine tetany and tenderness without any 
signs of maternal and fetal compromise. 
Grade 3: Usually concealed  haemorrhage  with  persistent  abdominal pain, vital signs are 
unstable, there is maternal tachycardia associated with orthostatic changes in the  blood 
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pressure .Fetal heart rate abnormalities are present  and abnormalities with coagulation may 
be evident in 30%. 
Grade 4: The patient may present with either or no vaginal bleeding or heavy vaginal 
bleeding with a tetanic uterus. There may be maternal shock, coagulopathy and fetal demise 
in most the cases.  
2.3 DIAGNOSIS  
Placental abruption is a clinical diagnosis (9). It should be suspected in women who present 
with vaginal bleeding or abdominal pain or both after 20 weeks of gestation or more. 
Placental abruption should also be suspected in all pregnant women with a history of trauma. 
The use of ultrasonography as a tool to diagnose placental abruption has been shown to be 
weak (9). According to the Glantz et al , the sensitivity has been reported  to be 24% with a 
specificity of 96%.The positive and negative predictive values were 88% and 53% 
respectively(30).However the same study noted that  ultrasonography failed to detect at least 
three –quarters of cases of placental abruption (30). 
The ultrasound appearance of an abruption depends largely on the size and the location of the 
bleeding, also the timing between the occurrence of the abruption and the time when the 
ultrasound examination is done (18). The pathologic findings differ between an acute 
abruption and chronic abruption .In the pathologic   examination of the delivered placenta an 
acute abruption can be confirmed by the presence of a fresh clot attached to the maternal 
surface of the placenta (31). In a chronic abruption there may be deposits of fibrin at the site 
of the abruption and infarcts may be seen overlying the placenta particularly on the maternal 
surface of the placenta (31). 
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The following ultrasonography criteria for the diagnoses of placental abruption have been 
described by Oyelese et al (18). 
1. Jello sign:  referring to the jingling of the placenta when sudden pressure is applied with the 
transducer. 
2. Pre-placental collection: referring to the collection that is between the placenta and 
amniotic fluid 
3. Retro-placental collection: referring to the clot that is between the myometrium and the 
placenta.  
4. Marginal haematoma: placental separation along the lateral edge of the placenta 
5. Sub-chorionic haematoma: is said to arise from the marginal abruptios. 
6. Increased   heterogeneous placental thickness 
7. Intra amniotic haematoma 
Glantz et al conducted a study in 2002 in which 149 patients were enrolled between the years 
1994 to 1996, the study was done in strong memorial hospital. The study looked at the clinical 
utility of ultrasound in the diagnoses and treatment of placental abruption (30). Of the 149 
patients studied, 17 (11%) had sonographic evidence of placental abruption but 32(21%) had 
evidence of placental abruption at delivery. The conclusion from this study was that 
ultrasonography was not sensitive for detection of placental abruption but a positive finding 
was associated with worse neonatal outcomes (30). Another important aspect is that a 
negative ultrasonography does not exclude an abruption (30). 
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2.4 MATERNAL COMPLICATIONS  
Placental abruption may lead to severe adverse outcomes for the mother. Haemorrhagic 
shock, disseminated intravascular coagulation (DIC), postpartum haemorrhage(PPH), acute 
kidney injury, Couvelaire uterus (which occurs when blood dissects into the myometrium 
towards the serosa), caesarean hysterectomy, uterine rupture, blood  transfusion, prolonged  
hospital stay, ICU admission and  maternal death have been associated with abruptio placenta. 
2.4.1 Disseminated intravascular coagulation (DIC) 
The presence of DIC indicates the severity of the abruption. (3).The reported incidence of 
DIC in the literature varies from 0.8% to 10% (1, 3, 32). The risk of DIC is highest when 
there is large placental detachment. The mechanism of DIC in abruptio placentae is 
multifactorial. A Couvelaire uterus causes abnormal uterine contractility and an atonic uterus 
which results in PPH. The fibrinogen degradation products (FDPS) that are released when 
DIC occurs can also affect the contractility of the uterus which may cause further PPH. FDPS 
can also act as anticoagulants which can further worsen the DIC.  DIC is a consumptive 
coagulopathy which is characterized by generalized activation of the coagulation system. DIC 
is never a primary but always secondary diagnoses which follow the release of 
thromboplastin, which is a pro-coagulant substance into the circulation (32). The released  
thromboplastins  lead to the activation of the  of the  clotting cascade  and  this may lead to 
the  rapid consumption  of the coagulation factors and platelets ,with deposition of fibrin in 
the  in the microcirculation  which leads to thrombocytopenia , defibrination and haemostatic 
failure.  
                                                                                                                                                                                                                                                                                           
The diagnosis is made on clinical grounds if a patient has bleeding tendencies and through 
blood tests such as the platelet count, international normalized ratio and activated partial 
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thromboplastin time (3).Bleeding tendencies may manifest with abnormal bleeding from 
venepuncture sites, gums and nose (3). The laboratory indicators of DIC are prolonged 
activated partial thromboplastin time and prothrombin test, low levels of platelets and high 
levels of fibrinogen degradation products (3).However, laboratory tests are in insensitive and 
more than 50% of clotting factors need to be consumed before they become abnormal.   
A scoring system has been described to measure the severity of DIC utilising all the 
coagulation tests (33).  A risk assessment is initially performed to determine if a patient has 
underlying disorders known to be associated with overt DIC. If the answer is suggestive, then 
one proceeds to use the scoring system (33). The coagulation tests that are used are 
protrombin time, platelet count and ˚ fibrinogen fibrin related marker. 
Scores are allocated as follows according to guidelines for the diagnoses and management of 
DIC (37), from the British journal of haematology. 
 Platelet count : 
 100×   =0  
 <100×   =1 
 <50×   =2 
 Elevated fibrin marker : 
-D-dimmer, FDPS  
 no increase =0 ,  
 Moderate increase= 2  
 Marked increase =3 
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 Prolonged PT:   
 <3s =0 
 >3s BUT <6s=1  
 6s =2 
 
 Fibrinogen level :  
 >1 g/l =0    
 <1g/dl=1 
If the score of >5 is suggestive of overt DIC, and a score of < 5 is non-overt DIC.  
The effective management is treating the underlying cause which is delivery of the baby and 
placenta and the condition usually resolves 12 hrs post-delivery (3, 33). The main goal of 
management is to restore and maintain circulating blood volume. This prevents kidney injury 
and further haemostatic failure that is caused by hypovolaemic shock (32). 
2.4.2 Haemorrhagic shock 
Abruptio placenta is often associated with significant blood volume loss which results in 
shock. Shock is defined as the clinical condition that occurs when there is hypo perfusion of 
the most vital organs (3, 34).  Bleeding can occur either vaginally or concealed within the 
uterus (3).  
In   pregnancy there is usually a physiological protection against haemorrhage as a result of 
high levels of coagulation factors and expansion of blood volume. However if blood loss 
exceeds 25% of total volume rapid hemodynamic deterioration occurs (3). 
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The management of haemorrhagic shock entails restoration of the effective circulating  
blood volume to improve tissue perfusion and avoid tissue necrosis of target organs (3). 
Initial treatment is by infusing crystalloids, followed by red cell replacement. Platelet 
transfusion may be necessary if the platelet count is 30/µL or there is oozing from the 
puncture sites (3). The response to the resuscitation is monitored by urine output which 
should be more than 0,5ml /kg/hr (3). If the patient has had a massive blood transfusion, 
potassium should be monitored to avoid hyperkalaemia (3). 
2.4.3 Postpartum haemorrhage (PPH) 
Postpartum haemorrhage can be classified into primary and secondary (35). Primary PPH is 
defined as the bleeding that exceed 500ml from the genital tract within 24 hours of the 
delivery of the baby(35).Secondary PPH is defined as bleeding that exceeds 500ml occurring 
between 24hours and 12 weeks (35). It can further be classified into minor and major. A 
minor PPH is referred to an estimated blood loss of 500ml and more, and major PPH refer to 
an estimated blood loss that is more than 1000ml (35). At caesarean section the estimated 
blood loss can be up to 1000 ml and if the delivery is vaginal the estimated blood loss can be 
up to 500ml. The reported incidence of PPH ranges from 16, 6% to 18, 9% in placental 
abruption (26, 36). The management can either medical or surgical owing to the multifactorial 
aetiology of PPH.  
According to the RCOG guidelines the management of PPH consists of four components 
namely (35): 
 Communication  
 Resuscitation 
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 Monitoring 
 Investigations 
In managing any emergency condition communication is the key, clinicians should seek 
the assistance of colleagues. Resuscitation of the patient with PPH should include 
evaluation of the air way, breathing and circulation and make sure that they are secure. 
As part of the management blood should be sent to the laboratory for assessment of full blood 
count, urea and creatinine and coagulation screen.    
 
Medical management of PPH 
Atonic uterus is usually the cause of PPH in patients with placental abruption the following 
medical treatment can be instituted. 
1) Bimanual uterine compression to stimulate uterine contractions. 
2) Empty the bladder. 
3) Syntocinon 5 units by slow intravenous injection. 
4) Ergometrine 0.5mg by slow intravenous or intramuscular injection. 
5) Syntocinon 40 u in 500ml Hartmann’s solution at 125 ml/hr unless fluid restriction is 
needed. 
6) Prostaglandin f2α can be given at a dose of 0.25mg by intravenous injection up to 8 
doses can be given. 
7) Misoprostol  1000mcg rectally 
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If medical treatment fails the following surgical interventions are considered. 
1) Balloon temponade 
2) Haemostatic brace suturing, B-Lynch 
3) Bilateral ligation of the uterine artery 
4) Bilateral ligation of the internal iliac artery 
5) Selective arterial embolization 
B- Lynch suture  
The B-Lynch suture was first described in 1997 by Christopher B-Lynch. It has been proven 
to be effective in the management of PPH (37).  The B-Lynch suture is a lifesaving procedure 
that is relatively safe and simpler than the other surgical techniques such as uterine and 
internal iliac artery ligation (37).  It has the ability to preserve the uterus as well as the fertility 
(37). This procedure was first done in patients that had life threatening postpartum 
haemorrhage. It was used in patients with placental abruption with PPH and DIC, prolonged 
labour, eclampsia in labour with PPH and DIC, Atonic uterus and major placentae praevia 
(37). When these patients were subsequently followed up they had good outcomes with no 
complications. The B-Lynch suture is better when compared to other techniques, which may 
be difficult to accomplish when expeditious management is required (37). Other techniques 
may not adequately control the bleeding more especially if there coagulopathy and an atonic 
uterus. To test the efficiency of this procedure a bimanual compression test is done, if the 
bleeding stops it means the brace suture can be applied. If this procedure fails to control the 
bleeding a more invasive procedure may be considered such as the hysterectomy 
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2.4.4 Acute kidney injury  
The diagnoses of acute kidney injury signify severe placental abruption. The incidence of 
acute renal injury associated with placental abruption is about 6% (9).The features are 
hyperkalaemia, hyponatremia, metabolic acidosis, and oliguria of less than 400ml in 24hours. 
Rising serum urea and creatinine levels are suggestive of acute kidney injury. 
The three forms of acute kidney injury that may occur are acute tubular necrosis, acute 
cortical necrosis and pre-renal failure. Prolonged ischemia from delayed treatment of 
hypovolaemia causes damage of the metabolically active tubular cells resulting in acute 
tubular necrosis which is reversible. Acute cortical necrosis is a severe form of renal failure 
that is irreversible, and the pathology involves the necrosis of the tubules and glomerulae 
throughout the kidney.  
Management can be conservative with complete recovery in pre-renal failure (9)  
2.4.5 Couvelaire uterus 
Couvelaire uterus occurs when the blood dissects through the myometrium towards the 
serosa. The diagnoses is usually made during caesarean section or during a laparatomy for 
post-partum hysterectomy (38).The uterus appears dark purple with poor contractility and 
thus becomes atonic (38). The complication was first described in 1911 by Alexendre 
Couvelaire who was a French Obstetrician. A wide range of incidence in quoted in the 
literature from 6% to 16, 5% (1, 8).     
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2.4.6 Peripartum hysterectomy 
Peripartum hysterectomy is associated with increased morbidity and mortality (39). It is 
performed at the time of delivery or in the immediate postpartum period. It is a lifesaving 
procedure that is done in severe cases of haemorrhage that are unresponsive to medical and 
surgical procedures (40). In a ten year review of emergency Peripartum hysterectomy (EPH) 
in a tertiary hospital which was conducted by Khan et al, the incidence of Peripartum 
hysterectomy was 16.5% in patients that had placental abruption (40).  Abbasi et al found that 
1.9% of cases were done Peripartum hysterectomy in order to control postpartum 
haemorrhage in patients with placental abruption (36). In the study by Khan et al, these 
patients that had hysterectomies had Couvelaire uterus which ultimately lead to uterine atony 
not responding to conservative management (40). The hysterectomy was done in order to save 
the women’s life. 
A subtotal hysterectomy is usually preferred method as it is safe and quick procedure, when 
the women’s condition requires immediate arrest of haemorrhage to save her life (40). It is 
associated with less blood loss, reduced operating time and reduced intra-operative and post-
operative complications (40). 
 
In the study by Khan et al the patients that had Peripartum hysterectomy had the following 
complications (40).  
 Septicaemia 
 Wound infection 
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 Burst abdomen 
 Paralytic ileus 
 Coagulopathy 
 Bladder injury 
 Ureteric injury 
 Hypovolemic shock 
 Renal failure 
 Pneumonitis and blood transfusions 
According to the literature the main complication is the need for blood transfusion (39) 
In view of the above morbidities that are associated with EPH conservative measures are tried 
to arrest the bleeding before considering EPH (40). The conservative measures include 
uterotonic drugs, haemostatic sutures uterine and systemic devascularisation. Conservative 
management is of importance in patients that are young, have low parity and are clinically 
stable (40).  
2.4.7 Blood transfusion 
Blood transfusion is an important morbidity associated with placental abruption. Blood 
transfusion is a lifesaving procedure. According to the RCOG guidelines blood transfusion 
should be initiated on both clinical and haematological grounds (35). 
According to the RCOG guidelines blood transfusion is rarely indicated in a stable patient 
with a haemoglobin of ≥ 10 g/dl, it is always indicated when haemoglobin of 6g/dl is found. 
According to RCOG guidelines on PPH for every 6 units of red cells give 4 units of FFP’S 
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(35). The incidence of blood transfusion in patients with placental abruption is between 
19.4% and 50 % (1, 4). 
A study of 106 patients with placental abruption by Bibi et al assessed risk factors and clinical 
outcomes. Fifty-four (50%) of patients needed blood transfusion and 5 patients needed 
massive blood transfusion (4). Massive blood transfusion is defined as an acute administration 
of more than half of the patients estimated blood volume per hour. This was comparable to a 
study done by Leunen et al who found that 43% of  patients needed blood transfusions(41).In 
contrast Pitaprom et al found that only 19.4% patients needed blood transfusions(1). 
2.5  FETAL AND NEONATAL MORBIDITY 
Placental abruption may have severe adverse outcomes for both the fetus and the neonate.  
The morbidities associated with placental abruption are preterm deliveries, intrauterine 
growth restriction, low APGAR scores, hypoxia, stillbirths, early neonatal deaths, and 
neurodevelopmental problems.  
Placental abruption has been found to be an independent risk factor for perinatal mortality. 
The perinatal mortality can be as high as 60-64% (5), but in developed countries it ranges 
between 9-12% (20, 42).  
2.5.1 Fetal distress 
Fetal distress is one of clinical presentations of placental abruption. There are explanations to 
this, during the early stages of placental abruption there is vasoconstriction that is induced by 
catecholamine’s which may selectively maintain the perfusion of the maternal heart and brain 
at the expense of utero -placental blood flow, therefore fetal distress is an important sign 
which shows that there hemodynamic compromise(3).According to the Nice guide lines  there 
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are four components that a clinician must comment on when interpreting fetal heart rate 
patterns namely: baseline heart rate, variability, accelerations and decelerations(43). 
Feature Normal value 
Normal baseline 110 – 160 b/min 
Baseline variability 5- 25b/min 
Accelerations  A rise of 15 b/min or more above the base 
line lasting for 15s 
Decelerations No deceleration should be present in a 
reassuring  CTG 
 
In a normal trace all four components should be reassuring. Fetal distress is recognized by the 
presence of two or more features that are non-reassuring or one or more features that are 
classified as abnormal. 
According to the South African literature Odendaal et al did a study that looked at patients 
that had early onset severe preeclampsia (42). The aim of the study was to look at the patients 
that were treated conservatively and those that ultimately had placental abruption, the 
perinatal mortality rates were compared between the study group which consisted of 69 
patients and controls which included 69 patients. They found a 67% prevalence of fetal 
distress in the placental abruption group, 58% had late decelerations on routine monitoring 
and half were accompanied by poor variability. Only 22% had fetal heart rate recording that 
were normal. Most of the patients in the abruption group presented with fetal distress than 
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presenting with the typical sign and symptoms of placental abruption, such as abdominal pain 
and vaginal bleeding (42).  
These findings show an importance of monitoring the fetal heart regularly in patients with 
severe preeclampsia as fetal distress is detected before any other signs of placental abruption 
(42). In a study that was conducted by Elsasser et al on the diagnosis of placental abruption  
looking at the relationship between clinical and histopathological findings, it was found that  
out of the 424 patients that were enrolled in the study about 16.1 % had non-reassuring fetal 
heart tracings  (9). 
2.5.2 Prematurity 
Prematurity is a significant contributor to the high perinatal mortality associated with 
placental abruption (44). Placental abruption has been associated with prematurity. 
Placental abruption is thought to cause preterm labour and patients with placental abruption 
may need delivery irrespective of gestational age. 
The mechanisms by which preterm labour cause   placental abruption are as follows: 
It is believed that there is a release of thrombin because of decidual placental haemorrhage 
and hemosiderin deposition which trigger labour leading to preterm delivery. 
Another theory is that: as a result of extravasation of blood at the placental margin that may 
lead to decidual necrosis which in turn could initiate the production of prostaglandins thereby 
leading to preterm birth.  
The incidence of prematurity has been quoted to be between 40-60%.Tikkanen et al did a 
study on clinical presentation and risk factors of placental abruption (20). In the study 198 
patients were recruited. Out of those 198 patients 53% of the patients had preterm births 
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(20).This was comparable to a study that was done by Ananth et al which was on placental 
abruption and adverse perinatal outcomes who found a 40% incidence of preterm birth (45). 
In the study by Ananth those pregnancies that were less than 32 weeks of gestation were 
greatly affected by placental abruption. In the same study even women that had the mild form 
of placental abruption the risk of preterm birth was increased (45). In a study conducted  by 
Pitaprom et al  on pregnancy outcomes of placental abruption a 56% incidence of preterm 
birth was found, among the premature neonates 44% suffered severe birth asphyxia and with 
the consequence of three neonatal deaths(1).      
2.5.3 Low birth weight and intrauterine growth restriction 
A vast majority of low birth weight seen in placental abruption is as a result of shortened 
gestation and growth restriction. 
Ananth and colleagues did a study on placental abruption and adverse perinatal out comes and 
found a 34.7% rate of low birth weight in the placental abruption group vs 6.7 in the group 
without placental abruption (45). The growth restricted babies had a 14.3% incidence in the 
placental abruption group versus 8.1 % in the group without placental abruption yielding a 
relative risk of 2.0(95%CI 1.5-2.4) (45). This was comparable to a study that was conducted 
by Ananth et al which looked at the placental abruption and perinatal mortality in the United 
States, an incidence of low birth weight was 46% (44). In contrast Pitaprom at al found a 65% 
incidence in a study that was conducted on pregnancy outcomes in placental abruption 
(1).There are neurodevelopmental outcomes that are associated with low birth weight such as 
cerebral palsy, cystic periventricular leukomalacia and periventricular haemorrhage. 
2.5.4 Neonatal ICU admission 
In most studies the reason for ICU admission is because of asphyxia and prematurity. 
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In a systemic review study by Obeidat et al on the parental experience of having an infant in 
the new born intensive care unit (46), It was found that the parents experienced high levels of 
distress such as depression, anxiety, trauma symptoms and feelings of powerlessness (46). 
They are also confronted with dealing with an environment that specializes with critical care 
and which is associated with a lot of demands (46). 
The early separation of the new born from the parents can also cause the strain in the infant-
parent relationship more especial during the lengthy stays in NICU, the parents may need to 
see, hold and touch their new born babies in order to facilitate early attachment and bonding 
(46). 
Therefore appropriate counseling is essential for these mothers. The newborns are also at risk 
of nosocomial infections because of the lengthy stays in the hospital.   
2.5.5 Stillbirth 
The risk of delivering stillbirths depends on the severity of the placental abruption (45).Two  
types of placental abruption are described namely complete and partial, complete separation 
of the placenta carries a higher risk of fetal death than partial separation .Ananth et al has 
quoted that the risk of still births increases if the placenta separates by over 50%(45). 
In the study that was conducted by Pitaprom et al on pregnancy outcomes of placental 
abruption it was found that 12.5% of pregnancies were complicated by still births (1). In 
contrast Abbasi found a 41% incidence of stillbirths (36). 
According to RCOG Guidelines if fetal death has been diagnosed, vaginal birth is usually 
recommended provided the maternal condition is satisfactory, but caesarean birth may be 
recommended for some women (47). 
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For those patients who have fetal losses, debriefing of both the partner and the mother is 
important. This has to be done as soon as possible while the women can still comprehend and 
communicate (47). All the events should be discussed with the family and they must be given 
an opportunity to ask questions (47). 
There are psychological problems that may follow such as postnatal depression and post-
traumatic stress disorder. Counseling should be offered to all women and their partners. The 
parents should be advised of support groups. A follow up plan should be made to see these 
women 4 to 6 weeks post-delivery for medical and psychological support. 
2.6 SHORT AND LONG TERM OUTCOMES OF PLACENTAL ABRUPTION. 
2.6.1 Cerebral palsy 
Kayani et al did a study on pregnancy out comes in severe placental abruption 33 cases were 
identified for the study. The infants  were followed up, the finding was that those that 
survived up to a year were (67%) and were developing normal at one year of age, and (24%)  
of infants died in the neonatal period(48). Of the surviving infants (12%) had cerebral palsy 
and two had sudden infant death syndrome in their first year of life. Another important 
finding was that 55% of the babies that were delivered within 20 minutes or less from the 
time of decision making had good outcomes (44). The decision to delivery interval greatly 
influenced the outcome this was evidenced by reduced neonatal morbidity and mortality. 
In another study by Spinillo et al which looked at the severity of abruption placenta and 
neurodevelopmental outcome in low birth weight infants (49). For the study a total of 40 
babies were recruited, their weight at birth was <2500g and 80 controls with similar weight 
and gestational age were used for the study. In the study it was found that those infants that 
were born to mothers with placental abruption had low Apgar scores. The infants of mothers 
who had grade 2 to 3 placental abruption required assisted ventilation and had fetal acidosis. 
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It was found that 10 infants needed assisted ventilation and 10 other infants had fetal acidosis, 
compared to only 2 infants that required assisted ventilation and had fetal acidosis in those 
mothers that had grade 1 placental abruption.  
A follow up of the surviving infants was done of the 40 infants: 36 infants survived and 
cerebral palsy was diagnosed in 4 infants (11%) and none of the infants in the controls had 
cerebral palsy. The cases of cerebral palsy included two infants that had spastic quadriplegia, 
two with quadriplegia and mental retardation. 
2.6.2 Intraventricular haemorrhage and cystic periventricular leukomalacia 
There are also neonatal intracranial lesions that can occur as a result of placental abruption. 
In the study by Spinillo at al an incidence of 17.5% of Intraventricular haemorrhage was 
found in infants whose mothers had grade 1 - 4 placental abruptions compared to only 5% in 
the control group. Gibbs at al found a high incidence of Intraventricular haemorrhage in the 
study that was conducted on neonatal intracranial lesions following placental abruption (50). 
In the study 29 infants were recruited following placental abruption over a 2 year period and 
similar controls were used. In the placental abruption group Intraventricular haemorrhage and 
haemorrhage into the brain parenchyma occurred in 72% compared to only 48% in the control 
group (50). 
According to the literature the risk factors for Intraventricular haemorrhage in low birth 
weight include high rates of abnormal fetal heart rates patterns, acidosis, low APGAR scores, 
assisted ventilation and neonatal hypotension. 
Intraventricular haemorrhage has got other complications such as: 
 Periventricular haemorrhagic infarction(PVHI)  
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 Post hemorrhagic hydrocephalus 
 Cerebellar hemorrhagic injury 
 Periventricular leukomalacia 
The above are important determinants for neonatal morbidity, mortality and long term 
neurological sequel. When the Intraventricular haemorrhage is complicated by PVHI the risk 
of major neurodevelopmental outcomes increases by 75%. 
2.6.3 Periventricular leukomalacia 
Studies have shown that cystic periventricular leukomalacia is another complication that can 
be found in infants whose mothers had placental abruption. An incidence of 5 - 34% has been 
found. Spinillo at al found that those infants that were born by mothers who had grade 2 to 3 
placental abruption had a risk of developing cystic periventricular leukomalacia (49). 
Periventricular leukomalacia is considered a marker of neonatal brain ischemia and is 
associated with moderate to severe developmental disabilities. 
In placental abruption there is a sudden interruption of maternal and fetal communication 
which results in severe ischemic event, as there is decreased cerebral perfusion, which is why 
it is not surprising to see high rates of cystic periventricular leukomalacia among surviving 
infants.  
2.7 DEFINITIONS 
Hypertension was defined as a systolic blood pressure of 140mmHg and a diastolic blood  
pressure of 90mmHg or more, on two occasions at least four hours apart or a single diastolic  
blood pressure reading of 110mmHg or more (11).  
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The following hypertensive disorders were described for the purpose of the study. 
Chronic hypertension was described as the hypertension that is present at the booking visit or 
before 20 weeks or if the women is already taking antihypertensive medication when referred 
to maternity services (11). 
Pre-eclampsia was diagnosed as the blood pressure that is accompanied with proteinuria after 
20 weeks of pregnancy (11). 
Gestational hypertension was defined as the hypertension that presents after 20 weeks of 
pregnancy without significant proteinuria (11).   
Unclassified hypertension was defined as the hypertension in the pregnant women whose 
blood pressure was not measured before 20 weeks of pregnancy (11).                                                                                                                                         
Gestational diabetes was defined as the diabetes that is first recognised in pregnancy after 20 
weeks and diagnosed by a positive oral glucose tolerance test.   
PROM was diagnosed if rupture of membranes occurred at less than 38 weeks gestation.  
An amniotic fluid index of more than the 95
th
 centile for the gestational age or a single 
deepest vertical pool of more than 8cm was used to diagnose polyhydramnios (17). 
The diagnostic clinical features of haemorrhagic shock included circulatory collapse with 
altered mental status, tachycardia of more than a 100bpm, oliguria of less than 30 ml/hr, 
tachypnoea of more than 20 breaths per minute, a fall in the systolic blood pressure to less 
than 80 mmhg and cold and clammy extremities (34). 
The diagnosis of DIC was described as a combination of the clinical picture such as abnormal 
bleeding from the gums, nose, and venepuncture sites together with laboratory tests. The 
laboratory component of diagnosis of DIC was determined by assessing the platelet count and 
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coagulation profile which consists of an INR and PTT (2). Thrombocytopenia was described 
as a platelet count of less than 150 per micro litre. The most abnormal INR and PTT results 
above the control were documented for the study.  
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3 PROBLEM STATEMENT 
Despite all the information we have gleaned from the literature the contribution of abruptio 
placentae to the maternal morbidity and perinatal morbidity and mortality rates at the Chris 
Hani Baragwanath academic Hospital is unknown.  
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4 MATERIALS AND METHODS 
4.1 Objectives 
1. To determine the frequency of abruptio placentae at Chris Hani Baragwanath Academic 
Hospital. 
2. To assess maternal risk factors common in the patients admitted with placental abruption. 
3. To determine the number of patients that had operative deliveries. 
4. To assess maternal morbidity associated with placental abruption. 
5. To assess perinatal outcomes of births in women with abruptio placentae. 
4.2 Setting of the study  
The study was done at the Chris Hani Baragwanath Academic hospital which is a tertiary 
referral hospital. Chris Hani Baragwanath Academic hospital is a busy hospital serving a low 
socio-economic population of Soweto and recorded a staggering 23 271 deliveries in 2011. 
Patients are referred from surrounding clinics and secondary hospitals. 
4.3 Study population 
The study population included all pregnant women who were diagnosed with placental 
abruption. A total of 60 patients were enrolled in the study. The patients for the study were 
recruited from the 18
th
 of May 2013 to 31 September 2013.                                                                                                                       
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4.4 Inclusion criteria  
All patients diagnosed with placental abruption whether the diagnosis was made clinically or 
by ultrasonography were included. The study also included patients who were diagnosed only 
at delivery, by presence of a retro-placental clot. These patients were delivered either 
vaginally or by caesarean section. 
4.5 Exclusion criteria  
Multiple pregnancies, placentae praevia, APH of uncertain origin and females who were 
younger than 18 years were excluded. 
4.6 Study design 
This was a prospective, descriptive study of the women diagnosed with placental abruption.   
4.7 Data collection and informed consent  
The management of all patients diagnosed with abruptio placentae at the Chris Hani 
Baragwanath Hospital obstetrics department includes admission into the maternity high care 
area. Daily rounds were performed by the primary investigator to identify patients diagnosed 
with placental abruptio. Ward rounds were also done in the postnatal ward where the patients 
that presented with ante partum haemorrhage were identified, also patients who had bad 
outcomes such as fresh still born and macerated still born were also identified. 
Some patients, diagnosed with abruptio placentae were transferred directly from the 
admissions ward to theatre therefore the admission ward register and caesarean section theatre 
register were also searched for to identify patients eligible for the study.  
A data collection sheet was assigned to each patient after informed consent to examine their 
records and those of their new-borns was signed. Patients were assigned a research 
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identification number to ensure that they remained anonymous. The patients who were unable 
to give consent owing to artificial ventilation and intensive care unit admission  were only  
included in the study once they were  able to give consent. The transitional intensive care unit 
and neonatal intensive care unit (ICU) registers were reviewed to determine perinatal 
outcomes of live births in women with placental abruption. The mode of delivery of all the 
patients was determined. 
4.8 Outcome measures  
4.8.1. Risk factors  
The risk factors that were studied in all patients were age, race, parity, and gestational age, 
number of antenatal visits, smoking, and use of recreational drugs such as cocaine and 
hypertensive disorders.                                                                                                                                                      
4.8.2 Maternal Outcomes 
The maternal outcomes that were assessed in the study were: haemorrhagic shock, DIC, renal 
failure, thrombocytopenia and PPH.  
The number of patients who required blood transfusions and the number of units of packed 
red cells that were transfused were assessed. The use of platelets and fresh frozen plasma was 
also determined.  Documentation was made of each patient’s lowest haemoglobin level (HB) 
and correlated to the need for blood transfusion and the number of units that were transfused. 
ICU admission, length of hospital stay, caesarean hysterectomy and maternal deaths were also 
assessed. Blood investigations relevant to the study were full blood count with platelets, urea 
and electrolytes and coagulation profile. 
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4.8.3 Perinatal outcomes 
Perinatal outcomes that were   evaluated include birth weight, prematurity, ICU admissions 
and the number of still births. The APGAR score at 5 minutes was also evaluated to exclude 
birth asphyxia. An Apgar score of 7 and above was considered normal and a score of less than 
7 was regarded as birth asphyxia.   
4.9 Statistical analysis 
Data management and analysis was done by transferring data from the data collection tool to 
Microsoft Excel. Descriptive statistics included statements of frequencies and percentages, 
means, standard deviation, and medians with ranges including interquartile ranges. If 
analytical methods were needed to compare data according to exposures or outcomes, the 
Fisher’s exact test for categorical variables and Student’s t-test or Wilcoxon ranksum test for 
continuous variables were used. A p-value < 0, 05 was considered as indicating statistical 
significance. The continuous data was presented using means ± standard deviation.  
4.10 Funding 
The study was funded by the investigator.  
4.11 Ethics 
Ethics approval was obtained from the HREC. The ethical issues that were raised with respect 
to the study were that some patients were distressed psychologically at the time of doing the 
study as a result of their adverse experience. Arrangements were made for them to be referred 
to the social worker and a psychologist for further counselling if they so wished 
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5. RESULTS  
5.1 Incidence and distribution of placental abruption 
 
Sixty patients were recruited with the diagnosis of placental abruption from the 18
th
 of May 
2013 to 31st September 2013. All had singleton pregnancies. There were 13734 deliveries 
during the study period at the CHBAH. The incidence of placental abruption was found to be 
0.4% in this study. There were 34 stillbirths and 26 live births. 
The youngest patient was 18 years and the oldest patient was 43 years. The mean age of 
patients was 28.2 ± 6.8 years. 
5.2 Gestational age on admission 
The mean gestational age at presentation was 32± 4.7 weeks.  As shown in table 5.1, 85% of 
the patients had gestational ages less than 37 weeks.  
Table 5.1 Gestational age at admission (n=60) 
Gestational age N  % 
20-25 4 6.6 
26-30 20 33 
31-36 27 45 
37-40 9 15 
5.3 Risk factors 
The maternal risk factors for placental abruption are presented in Table 5.2.  The majority of 
patients had parity of 1 and more accounting for 46(76.6%) of the cases. Placental abruption 
occurred in 4(6.7 %) of patients that had a previous history of placental abruption. Placental 
abruption occurred in 7 (11.7%) of patients that had previous caesarean section. Smoking as a 
risk factor was found in 5 (8.3%). 
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Table 5.2   Demographic characteristics of patients with placental abruption  
Characteristic N % 
Age in years 
<20 
21-24 
25-29 
30-34 
35-39 
≥ 40 
 
 
 
Parity    : 0 
               :≥1 
 
7 
16 
12 
12 
9 
4 
 
 
 
14 
46 
 
11.6 
26.6 
20 
20 
15 
6.6 
 
 
 
23 
76.6 
Race : African 56 93. 
          : other  4 6.7 
Booked antenatal care 53 83 
Previous placental 
abruption 
4 6.7 
Previous caesarean  section 7 11.7 
Smoking  5 8.3 
Cocaine use 0 0 
5.4 Pregnancy characteristics 
As shown in Table 5.3, 55% of patients had hypertensive disorders.  Pre-eclampsia was found 
in 24(40%) of the patients, but 15(25%) of those patients had severe pre-eclampsia. 
Gestational hypertension occurred in 5(8.3%) cases and chronic hypertension occurred in 4 
(6.7%) of the cases. In the study fibroid uteri were found in 2 (3.3%) of the cases. 
Table 5.3 Pregnancy characteristics of patients with placental abruption (n=60)  
Characteristic N  % 
Mild pre-eclampsia 9 15 
Severe pre-eclampsia 15 25 
Chronic hypertension 4 6.7 
Gestational hypertension 5 8.3 
Gestational diabetes 1 1.7 
HELLP syndrome 5 8.3 
Fibroid uterus 2 3.3 
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5.5  Clinical presentation  
Seventy percent of subjects in the subgroup that had stillbirths presented with vaginal 
bleeding and 27(79.4%) had abdominal pain. In the subgroup that had live births, 18 (69.2%) 
of cases had vaginal bleeding and 9 (34.6%) had abdominal pain. Retro-placental clots were 
detected on ultrasound in 13 (41.9%) of the subjects in the stillbirth subgroup and in 3(12.5%) 
of the cases that had live births.  
Of the sixty patients only 24(20.5%) of the patients had CTG on admission: In the subgroup 
that had stillbirths, category 1 was seen in 1(2.9%), category 2 was found in1 (2.9%) and 
category 3 was found in 5(14.7%) of subjects. In the subgroup that had live births, category 1 
CTG was found in 5(19.2%), category 2 was found in 5(19.2%) and category 3 was found in 
7(26.9%) of the cases. As shown in Table5.4, a systolic blood pressure of ≥ 140 mmhg was 
found in 5(14.7%) of cases in the stillbirth subgroup versus7 (26.9%) in the group that had 
live births. A systolic blood pressure of ≥ 160mmhg was found in 11(32.3%) of cases that had 
still births versus 6(23%) in the subgroup that had live births. 
The mean systolic blood pressure was 137 ± 33 mmHg in the group of patients that had still 
births versus the mean systolic blood pressure of 143 ± 26 mmHg in the group that had live 
births. A diastolic blood pressure of ≥ 90 mmhg was found in 16(47%) of the cases in the 
placental abruption group that had stillbirths versus3 (8.8%) in the group that had live births.  
A diastolic blood pressure of ≥110 mmhg was found in 5(14.7%) in the group that had still 
births versus 8 (30.7%) in the group that had live births. The mean diastolic blood pressure 
was 86±21mmHgin the group that had stillbirths versus the diastolic blood pressure mean of 
89 ±21mmHg in the group that had live births. Oligohydramnios was found in 4(15.3%) of 
the subjects in the placental abruption subgroup that had live births. Pre-labour rupture of 
membranes was found in 1(2.9%) of subjects in the placental abruption group that had 
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stillbirths and 2(7.7%) was found in the subgroup that had live births.  There were no patients 
that presented with a history of trauma. 
 
Table 5.4 Clinical manifestations of placental abruption on admission 
Stillbirths (n=34)  live births (n=26) 
Characteristic N  % N  % P -value 
Vaginal bleeding 24 70.6 18 69.2 1.00 
Abdominal pain 27 79.4 9 34.6 <0.01 
Ultrasound finding  
of Retro placental 
clot 
13 41.9 3 12.5 0.02 
No Retro placental 
clot on ultrasound 
 
18 58.1 21 87.5  
CTG findings 
category 1 
category 2 
category 3 
Intrauterine fetal 
deaths 
Not done 
 
1 
1 
5 
25 
 
2 
 
2.9 
2.9 
14.7 
73.5 
 
5.9 
 
5 
5 
7 
0 
 
9 
 
19.2 
19.2 
26.9 
0 
 
36.6 
N/A 
cervical dilatation 
≤3cm                         
≥4cm 
 
27 
7 
 
79.4 
20.6 
 
18 
8 
 
69.2 
30.7 
0.39 
SBP 
≥140 
≥160 
 
5 
11 
 
14.7 
32.3 
 
7 
6 
 
26.9 
23 
 
0.33 
0.57 
DBP 
≥90 
≥110 
 
 
16 
5 
 
47 
14.7 
 
3 
8 
 
8.8 
30.7 
 
<0.01 
0.21 
Oligohydramnios   0 0 4 15.3 0.03 
IUGR 1 2.9 3 11.5 0.31 
Trauma 0 0 0 0 1.00 
Prom 1 2.9 2 7.7 0.57 
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5.6  Laboratory results 
The mean maternal haemoglobin was 7.8 ± 2g/dl in the placental abruption group that had 
stillbirths. In the group that had stillbirths, 17 (50%) of the patients had haemoglobins that 
were <7 g/dl and10 (29.4%) had haemoglobins between 7-9g/dl and 7(20.5%) had 
haemoglobins of ≥10g/dl.  In the group that had live babies, 2(7.7%)  of patients had  
haemoglobins less than 7g/dl , the mean haemoglobin was 12±2g/dl, and  about 24(92%) of 
the patients had haemoglobins that were ≥ 10g/dl .The mean maternal urea was 2.8±  
1.8mmol/L and the mean creatinine of 61±22µmol/l in the group that had live births .The 
mean maternal urea was 5.5± 3.7 mmol/land mean creatinine of 150±149µmol/l  in the group 
that had still births. In the placental abruption subgroup that had live births the mean platelet 
count was 218± 77 µ/l and the mean INR was 1.06 ± 0.2.The mean PTT was found to be 28± 
7seconds in this group. In the group that had still births the mean platelet count was 123 µ/l   
± 67 and the mean INR was 1.31 ± 0.5.The mean PTT was found to be 35 ±11seconds in this   
group. 
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Table5.5. Biochemistry of the patients compared between the group that had live births 
and those with stillbirths. 
Stillbirths (n=34)   Live births (n=26) 
Laboratory 
test 
N % N %  P-value 
      
Haemoglobin 
level 
<7g/dl 
7-9g/dl 
≥10g/dl 
 
 
17 
10 
7 
 
 
50 
29.4 
20.5 
 
 
2 
0 
24 
 
 
7.7 
0 
92 
<0.01 
Platelet  count 
<50 
50-99 
100-149 
≥150 
 
5 
11 
4 
14 
 
 
14.7 
32.2 
11.7 
41 
 
0 
1 
5 
20 
 
 
0 
3.8 
19.2 
76.9 
<0.01 
Urea level 
<5 
5-9.9 
≥10 
 
21 
8 
5 
 
61.7 
23.5 
14.7 
 
19 
2 
0 
 
90.4 
9.5 
0 
0.05 
Creatinine 
level 
<75 
75-124 
125-249 
≥250 
 
11 
12 
5 
6 
 
32.3 
35.2 
14.7 
17.6 
 
16 
5 
0 
0 
 
76 
23.8 
0 
0 
 
<0.01 
INR 
<0.95 
0.95-0.99 
1.00-1.49 
≥1.50 
 
0 
4 
6 
2 
 
 
0 
36.3 
54.5 
18.1 
 
 
1 
1 
1 
0 
 
 
33.3 
33.3 
33.3 
0 
0.20 
PTT 
15-29 
30-49 
≥ 50 
 
3 
7 
1 
 
25 
58.3 
8.3 
 
1 
2 
0 
 
33.3 
66.6 
0 
0.86 
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5.7  Maternal outcomes and hospitalisation 
PPH occurred in 15 (44%) of patients that had placental abruption with stillbirths compared to 
1(3.8%) of patients that had placental abruption with live births. 
Haemorrhagic shock was observed in 2(5.9%) of patients that had placental abruption with 
stillbirths. Acute kidney injury was seen in 20(58.8%) of patients that had stillbirths compared 
to 3 (11.5%) in the group that had live births. DIC was observed in 8 (23.5%) patients that 
had stillbirths.  Couvelaire uterus was observed in 9(26.4%) of cases that had stillbirths. 
Hysterectomies were performed in 2(5.8%) of the cases.  A total of 5(14.7%) of patients 
required ICU admission in the placental abruption group that had stillbirths. The duration of 
hospital stay in the patients that had live births, 50% stayed for less than 4 days and 3.85% 
stayed for ≥12 days. In the group that had stillbirths, 17.6% of patients stayed for less than 4 
days, 38.2% stayed in the hospital between 4 to7 days and 26.5% stayed for ≥12 days.  . 
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Table5.6 Maternal out comes giving details on the complications and mode of delivery  
Stillbirths (n=34)  Live births (n=26) 
Complication  N   %  N % P-value 
DIC 8 23.5 0 0 <0.01 
PPH 15 44.1 1 3.8 <0.01 
SHOCK 2 5.9 0 0 0.50 
Renal failure 20 58.8 3 11.5 <0.01 
Couvelaire 
uterus 
9 26.4 0 0 <0.01 
ICU 
Admission 
5 14.7 0 0 0.06 
Hysterectomy 2 5.8 0 0 0.50 
Mode of 
delivery 
 
NVD 
C/S 
Vacuum 
delivery 
 
 
 
15 
18 
1 
 
 
 
44 
52.9 
2.9 
 
 
 
4 
22 
0 
 
 
 
15.3 
84.61 
0 
 
0.01 
 
 
In the placental abruption group that had stillbirths, 10(29.4%) of patients required < 4 units 
of blood and 13(38.2%) of patient’s required ≥ 4 units. In the group that had live births, 
6(23%) required blood transfusion and all required less than 4 units of blood. In the group that 
had stillbirths 13(38.1%) of the patients required the transfusion of fresh frozen plasma. No 
patients in the live birth group required transfusion of fresh frozen plasma. 
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Table 5.7 Transfusion of Blood products and estimated blood loss  
Stillbirths (n=34)  live births (n=26) 
Complication No % N % P-value 
Units of blood 
transfused 
< 4 
 
≥4 
 
 
10 
 
13 
 
 
29.4 
 
38.2 
 
 
 
6 
 
0 
 
 
23 
 
0 
 
 
 
0.77 
 
<0.01 
 
Units of FFP’S 
transfused 
<4 
≥4 
 
 
12 
1 
 
 
35.2 
2.9 
 
 
0 
0 
 
 
0 
0 
 
 
<0.01 
1.00 
Units of 
platelets 
transfused 
0 0 1 3.8 1.00 
Blood loss 
<500ml 
500-999ml 
1000-1999 
≥2000 
 
7 
13 
4 
7 
 
 
22.5 
41.9 
12.9 
22.5 
 
 
5 
19 
2 
0 
 
19.2 
73.0 
7.6 
0 
 
0.03 
 
5.8 Percentage of an abruption 
As shown in Table 8, 15 (62.5) % of   patients in the group that had stillbirths had complete 
placental abruption and 7(29%) of patients had an abruption between 50-90%. In the group 
that had live births, only 15 of the 26 patients had their degree of placental separation 
quantified and less than 50% of placental separation was found. 
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Table 5.8 Frequency distribution by the percentage of an abruption 
Still births (n=24)  Live births (n=15) 
Percentage  N   % N  % P-value 
<50% 2 8.3 15 100 <0.01 
50-99% 7 29 0 0  
≥100% 15 62.5 0 0  
 
5.9 Birth weight at delivery 
The mean birth weight was 1760 ±89.3g in the stillbirth group compared to1983± 998g   in 
the group that had live births. 
 
Table 5 9 Frequency distribution according to birth weight 
Still births (n=34)  Live births (n=26) 
Birth weight N   %  N % P-value 
<500 1 2.9 0 0 0.76 
500-1499 15 44.1 10 38.4  
1500-2499 10 29.4 8 30.7  
≥ 2500 8 23.5 8 30.7  
 
5.10 Neonatal outcomes 
As shown in Table 5.10, there were 5(19.2%) babies that had birth asphyxia and 7(26. 9%) 
had APGAR scores of 7-8. ICU admission was required in 11(42.3%) of the cases. 
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Table 5.10 Neonatal out comes detailing the APGAR score, neonatal ICU admission   
APGAR Score at 
5minutes 
N  % 
<7 5 19.2 
7-8 7 26.9 
9-10 14 53.8 
 ICU admission 11 42.3 
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6 DISCUSSION 
In this study 60 patients were recruited and the incidence of placental abruption was found to 
be 0.4% .This was comparable to the finding by Tikannen et al who reported an incidence of 
0.42% in a study that was done in a tertiary referral university hospital in Finland (20).In 
contrast, an incidence of 1% has been reported in a Japanese study on (5, 6) perinatal outcome 
of placental abruption modified by clinical presentation. Chris Hani Baragwanath is a tertiary 
referral hospital for high risk patients and therefore, the incidence is similar to what has been 
reported in the literature. 
The risk factors that were found in this study were similar to risk factors reported in other 
studies. A history of a previous placental abruption was reported in 6.7% of the patients and 
this was similar to what was reported by Tulpar et al (8). It is important to counsel patients 
about the risk of recurrence with subsequent pregnancies. 
One patient was a 34 year old G3P1, who was a poorly controlled chronic hypertensive and 
had placental abruptions with stillbirths at 24 and 36 weeks in previous pregnancies and 
suffered another abruption at an early gestation of 20 weeks. The occurrence of abruptions 
from as early as 20 to 24 weeks of gestation has been documented in case reports (3). 
The patient was also diagnosed with anti-phospholipid syndrome and Enoxaparin 40mg daily 
and aspirin 75mg daily was initiated at 12 weeks of gestation.  Both inherited and acquired 
thrombophilia have been implicated as risk factors for placental abruption. Anti-phospholipid 
syndrome is an acquired thrombophilia which is associated with placental vascular 
thrombosis, decidual vasculopathy and placental infarction.  
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Eighty three percent of the study subjects were booked patients. This is in contrast to findings 
by Bibi et al from Pakistan who reported that lack of antenatal care was the risk factor for 
placental abruption (4). 
Previous caesarean section was reported in 11.7% of the subjects, which was higher than the 
7.8% incidence reported in a study from Thailand on pregnancy outcomes in placental 
abruption (1). 
Smoking was found in 8.3% of the patients but information about pack history was not part of 
the study. Studies have reported a dose dependent relation between placental abruption and 
smoking (19). 
In this study we also found a higher incidence of 76.6% of placental abruption in patients that 
had parity of one and more. A lower incidence of 23.3% was found in primigravida patients. 
There was no increase in the incidence of placental abruption with advanced maternal age as 
previously reported by Tulpur et al (8). 
Hypertensive disorders are important known risk factors for placental abruption (13, 14). 
During the study period pre-eclampsia was reported in 40% of the patients and severe pre-
eclampsia was reported in 25% of the patients. The incidence of chronic hypertension was 
6.7% .This is in contrast to conclusions from other studies that found chronic hypertension not 
to be a risk factor for placental abruption (15). However, chronic hypertension with super-
imposed pre-eclampsia was not found to be a risk factor as previously reported by Ananth et 
al as there were no patients in this study that had chronic hypertension with super-imposed 
pre-eclampsia (15). HELLP syndrome was found in 5 patients with severe pre-eclampsia. 
In this group of patients with hypertensive disorders only two patients recorded a single clinic 
visit whilst the rest were booked.  The majority of these patients were admitted with 
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uncontrolled blood pressures of ≥ 140/90mmhg. Detailed information about the compliance of 
treatment was not part of the scope of the study. Hence, possible reasons for uncontrolled 
blood pressures requiring admission cannot be attributed to non- compliance or poor 
optimisation.  In some of the patients the abruption occurred while admitted in the ward for 
blood pressure optimisation.  
One patient had excessive anticoagulation and this was suspected to be the cause of the 
abruption. She was a 35 year old P4G5 known cardiac patient with mitral stenosis who 
presented with a sub-therapeutic INR level of 1.5 and was admitted to optimise her 
anticoagulation. Her INR level was noted to be increased to 5.6 after she started having per 
vaginal bleeding.  
Over-warfarinization was suspected to be the cause of placental abruption as she did not have 
other risk factors. First trimester fetal exposure to warfarin in the first trimester is documented 
to cause warfarin embryopathy. In the later trimesters it may cause fetal bleeding, still births 
and neonatal deaths but overwarfarinization has not been found to be the risk factor for 
placental abruption according to the literature. 
Uterine myomas were reported in 3.3% of the patients. A study on ultra-sound diagnosis of 
uterine myomas and complications in pregnancy found that placental abruption was evident in 
those women that had myomas sizes greater that 200cm3 and with sub mucosal myomas. 
Therefore it is important to counsel pregnant patients with uterine myomas about the risk for 
placental abruption.    
This study further divided patients according to whether they had live babies or dead babies. 
Of the 34 patients that had still births, 52.9% of the patients had caesarean section deliveries 
compared to 84.6% of the patients that had caesarean section deliveries in the group that had 
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live babies. The remaining 15.4% of patients with live babies delivered by normal vaginal 
delivery as the delivery was imminent or the placental abruptions was undiagnosed.   
Department protocol is to aim for delivery by normal vaginal route if an intra-uterine fetal 
death is diagnosed with an abruption provided there is no maternal compromise. This 
management protocol is in keeping with recommendations by RCOG guide lines (47). 
Indications for delivery by caesarean section in patients with intra-uterine fetal deaths were 
compromised maternal condition and unfavourable cervical Bishop Scores for induction of 
labour. The higher caesarean section rate in the placental abruption group that had live babies 
can be justified by department management protocol. All patients who presents with a live 
and viable baby with placental abruption are delivered by caesarean section unless vaginal 
delivery is imminent.  
Haemorrhagic shock occurred in 5.9% of the cases that had stillbirths. One of the patients 
with shock was diagnosed clinically with DIC when her blood samples for coagulation screen 
wouldn’t clot .She was a 21 year old P1G2 patient who was admitted to labour ward in the 
advanced phase of labour and a cervical dilatation of 9cm. An ultrasound revealed an 
intrauterine fetal death but no retro-placental clot was noted. Soon after admission to labour 
ward she started bleeding actively, her blood pressure started dropping and her level of 
consciousness was also altered. A diagnosis of shock was made and resuscitation was 
commenced. She did not meet the criteria for assisted vaginal delivery nor was delivery 
imminent. A caesarean section was performed in accordance with departmental protocol for 
resuscitation after maternal cardio-pulmonary arrest where cardiac output is not restored 
within four minutes of commencing resuscitation.   Post-delivery examination of the placenta 
revealed 100% placental abruption. Resuscitation was successful after caesarean section.  She 
was subsequently admitted to ICU for 7 days and discharged after 5 days post ICU discharge. 
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She was also diagnosed with acute kidney injury in ICU which recovered completely. This 
case highlights the dangers of concealed abruptions and the difficulty in diagnosis as well as 
the possible rapid deterioration of maternal condition. Hence, there should be a high index of 
suspicion in intra-uterine fetal deaths of unknown aetiology. 
Acute kidney injury was found in 58.8% of the patients which was higher than the finding by 
Tulpar et al (8). It was difficult to differentiate whether the kidney injury was as a result of the 
underlying disorder as some of the patients had hypertensive disorders which were 
complicated by renal dysfunction or if it was as a result of placental abruption itself. 
A higher incidence of acute kidney injury was found in patients that had stillbirths. All 
patients were managed conservatively except two patients that required dialysis, but they all 
recovered completely. Those that were treated conservatively were given intravenous fluid 
and input and output monitoring was done for them. 
Patients that had stillbirths also had a higher incidence of PPH. One possible explanation 
could be that there was a higher incidence of 26.4% of Couvelaire uteri which were found in 
patients that had still births. Pitaprom and Tulpar et al reported incidences of Couvelaire uteri 
of 16.5% and 6% respectively (1, 8).  Couvelaire uteri were found in patients that had 
placental abruptions of more than 50%. Couvelaire uterus is a risk factor for uterine atony 
(40).  Uterine atony was found in 10 patients. All were managed medically with   utero-tonics 
such as Syntocinon, Ergometrine and prostaglandin f2 alpha. If there was no response to 
medical treatment, conservative surgical management with a B-Lynch suture was performed. 
Six  B-lynch sutures were performed and all six patients presented with massive placental 
abruptions of between 70% and 100% .They all had  atonic uteri secondary to Couvelaire 
uteri and failed medical treatment.  Only one patient had a hysterectomy secondary to 
uncontrolled PPH. She was a 19 year old patient G1P1 at 36 weeks who had an 80% 
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abruption with a dead baby. Intra-operatively the patient lost more than 2litres of blood and 
was suspected to be in DIC as she was oozing from the uterine incision wound and also had 
an atonic uterus. The patient received 9 units of blood and 6 units of FFP. The atonic uterus 
did not respond to medical treatment which included Syntocinon, syntometrine and f2 alpha 
nor a B-lynch suture.   
The other hysterectomy in the study was for puerperal sepsis. This patient was a 27 G2P1 at 
33 weeks who had an atonic uterus secondary to Couvelaire uterus. She also received both 
medical and surgical management with a B- lynch suture and good uterine contractility was 
achieved. On day 4 post operation the patient presented with abnormal septic markers. 
Findings at relook laparatomy revealed a septic uterus and total abdominal hysterectomy was 
performed. Her identifiable risk factors for puerperal sepsis were the prolonged duration of 
her caesarean section and intra-operative complications.  
In this study 48% of patients required blood transfusion. This was comparable to the finding 
by Bibi et al who found that 50% of the patients required blood transfusions (4).The need for 
blood transfusion was found in 67.6% of the 34 patients that had still births. In the stillbirth 
group there were five patients that required massive transfusion, 2 (5.88%) required 5 units of 
blood, 2(5.88%) required 6 units and the other patient received 9 units. The decision to 
transfuse blood was based on the clinical judgement of the attending clinician or correlated to 
the patient’s haemoglobin.  
ICU admission was required in 5 patients. Indications for ICU admission were either contra-
indications to extubation or if the patient had an underlying medical condition such as a 
cardiac condition. One patient was a known cardiac patient with mitral stenosis and therefore 
required post-operative observations in ICU.  The other four patients could not be extubated 
as they had acidosis as the result of the PPH that occurred intra-operatively. 
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The other significant common observation was that all 5 patients had 100% placental 
abruption and 4 complicated with PPH. All these patients were successfully resuscitated and 
discharged. These observations suggest that an abruption of more than 50% may carry a high 
morbidity. 
There was a high incidence of babies born prematurely, which is in agreement with other 
studies (20, 45). In this study 76.4% of babies had low birth weight in the group that had still 
births compared to 69.4% in the group that had live births. The strong association of placenta 
abruption with prematurity may be attributed to the management of placental abruptions with 
delivery irrespective of the gestation. The other important contributor to neonatal morbidity is 
the contra-indication to tocolysis for induction of fetal lung maturity with steroids. In 
addition, babies born to mothers with placental abruptions are usually smaller for gestation as 
fetal growth restriction may occur with maternal conditions such as hypertensive disorders 
resulting in placental insufficiency. (44).  
The other important morbidities include birth asphyxia and acute respiratory distress 
syndrome which may require ICU admission for ventilation and monitoring. In this study the 
incidence of babies that required ICU was found to be 42.3% of the babies. The reasons for 
ICU admissions were low birth weight, prematurity, acute respiratory distress syndrome and 
birth asphyxia. 
The most significant finding was that patients with more than 50% placental abruption were 
more likely to have a stillbirth which was similar to the finding by Ananth et al (45). The 
clinical presentation of the patients was similar to what has been reported by the literature (9). 
In this study the patients presented with per vaginal bleeding and abdominal pains unless they 
had a concealed abruption. Fetal distress was found in 26.9 % of the patients that had live 
babies which is a common presentation in patients that have placental abruption.    
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Limitations  
1. There were patients that were diagnosed, treated and discharged from the high care area 
before the primary investigator identified them as eligible for the study.  
2. The Department protocol is that all complicated patients be admitted to ward 64. During 
the study period some of the patients were admitted to postnatal wards for uncomplicated 
patients owing to bed shortages. These patients were mostly delivered by normal vaginal 
delivery. It was not part of the study methodology to enrol patients from those post natal 
wards. Hence, some patients with abruption may have been missed during the study period 
3. Incorrect diagnoses of the patients. Patients who were thought to have placental abruption 
but post -delivery findings were negative. These patients were not included as there was no 
demonstration of retro-placental clot at delivery.  
4. Some of the patients declined consent to be included in the study  
5. There was also poor documentation of the events and missing records.  
6. The other weakness in the study was that after delivery of the placenta, clinicians did not 
quantify the percentage of the abruption. The only documentation found was of ‘small’ and 
‘big’ clots.  This limited us in understanding whether the bad outcome was as result of the 
placenta separating completely or partially. 
7. Not all the patients with placental abruptions had renal function tests. If the patient was 
found to be stable, the investigation was not performed. Hence, there could be an under- 
reporting of acute kidney injury associated with placental abruption. According to the 
departmental protocol all patients should have a baseline renal function assessment on 
admission if an abruption is suspected but that opportunity was missed in some patients.  
 
8. Babies that were born alive were not followed up to report on late neonatal deaths after 7 
days.  This was not part of the scope of this study. 
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Conclusion 
 
Placental abruption carries a significant risk for both maternal and fetal morbidity. The 
prevalence of placental abruption was found to be 0.4% in this study which was similar to 
what has been reported in the literature. Antenatal risk factors associated with this condition 
must be identified and the importance of antenatal care should be emphasised. In the study 
hypertensive disease remains an important risk factor for this condition. These risk factors can 
be obtained from the patient’s history and can thus help in reducing the morbidity and 
mortality associated with this condition. Prompt diagnosis and early referral of the patients for 
tertiary level care can result in better outcomes in these patients. A significant finding of this 
study, was the worse outcomes in patients that had placental abruption and stillbirths. This 
signifies the importance of early recognition and proper referral of the patient to ensure 
adequate management.  
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8. APPENDICES 
DATA SHEET 
Descriptive study of severe morbidity in women with abruptio placentae 
Research study no: _____ 
Age: _______ 
Race: ___ _African_ _ _Caucasian_ __Asians___ _Mixed 
Antenatal attendance: yes/ no / how many visits ____ 
Gestational age at presentation: By sonar/LMP/Palpation 
OBSTETRIC HISTORY 
Parity   : _______ 
Gravidity   : _______ 
Previous history of placental abruption: yes / no 
Previous caesarean section:  yes /no if yes how many _________ 
CORMOBIDITIES 
Hypertensive   disorders: yes / no if yes which one (pre-eclampsia/chronic 
hypertension/chronic hypertension with superimposed pre-eclampsia) 
Gestational diabetes: yes or no 
HABITS 
Smoking: yes / no______             cocaine use   : yes /no 
CLINICAL PRESENTATION 
Vaginal bleeding__ ____           Abdominal pain_____________ CTG: category 1/2/3 
CLINICAL DIAGNOSES 
General   condition 
Colour_____   normal or pale        Pulse____           Blood pressure_____     respiratory 
rate____________ 
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Abdominal palpation: Tenderness yes/no___________ consistency: hard/soft   symphysis-
fundal height: ______________in cm 
Vaginal Exam: bleeding Present/absent,  
Cervical dilatation: os closed / open   if open how many cm 
Syntocinon:  given / not given________ 
 
PERINATAL OUTCOMES OF LIVE BABIES 
 
APGAR SCORE AT 5 MINUTES 
 
 
BIRTH WEIGHT 
 
 
PREMATURITY 
 
 
ICU ADMISSION 
 
Yes /No 
 
DEAD BABY: FRESH STILL BORN OR MACERATED STILL BORN 
BIRTH WEIGHT: 
 
GESTATIONAL AGE:                          
 
INVESTIGATIONS ON ADMISSION AND THE WORST RESULTS TO BE USED 
HAEMOGLOBIN  
 
 
PLATELETS 
 
 
UREA 
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CREATININE 
 
 
INR  
 
 
PTT 
 
 
SONAR(RETROPLACENTAL CLOT) 
 
YES/NO 
 
MATERNAL OUT COMES                                                  
DIC 
 
 
POSTPARTUM HEAMORRHAGE 
 
BLOOD LOSS= 500ML OR 1000ML AND 
MORE 
SHOCK 
 
BP=        PULSE=   RESPIRATORY 
RATE=       URINE OUTPUT=                     
MENTAL STATUS  
RENAL FAILURE 
 
UREA=        CREATININE= 
NEED FOR BLOOD TRANSFUSION 
 
 NO OF PACKED CELLS USED 
NO OF PLATELETS AND FFPS   
LENGTH OF HOSPITAL STAY 
 
 
ICU ADMISSION 
 
YES /NO 
CEASARIAN HYSTERECTOMY 
 
YES/NO 
 
DURATION OF ICU STAY: 
REASON   FOR   ICU ADMISSION: 
MODE OF DELIVERY: 
COMPLETE OR PARTIAL PLACENTAL ABRUPTION 
ESTIMATED   BLOOD LOSS: 
FINAL OUT COME: discharge / death 
OTHER COMPLICATIONS AT DELIVERY: 
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STUDY PARTICIPANT INFOMATION SHEET 
 
TITLE: DESCRIPTIVE STUDY OF MORBIDITY IN WOMEN WITH ABRUPTIO 
PLACENTAE 
 
Good day. My name is Dr Bongiwe Nkomo.  I work in the department of obstetrics and 
gynaecology at Chris Hani Baragwanath hospital. I would like to invite you to participate in a 
research study entitled “A descriptive study of morbidity in women with abruptio placentae.”  
Why are we doing the study? 
The reason why am doing the study is because you have had the condition where the placenta 
separated before the baby is born and as result of that there is a risk of you developing the 
complications associated with this condition. 
What will happen if you take part in this study? 
If you agree to take part in the study, I would like to ask a few questions to know more about 
yourself and would also like to review your records, The information that will be collected is 
that pertaining to the risk factors that may have predisposed you into getting this condition, all 
complications that have occurred as result of this condition, blood results and the baby’s 
outcome. All the information provided will be kept confidential.  There are no costs to you for 
participating in the study. 
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What are benefits of being in the study? 
By participating in the study you may not receive a direct benefit. However your participation 
in the study may help us understand the condition in this community better.  
What are the risks and discomfort of being in this study? 
You may experience some distress because of what has happened to you but we will arrange a 
social worker or psychologist to speak with you if you would like that. 
What happens if you do not agree to take part in this study? 
Your participation in the study is voluntary. 
You may withdraw from the study at any time, and your withdrawal will not change your 
treatment. You will be treated the same whether you are part of the study or not. 
How is the information collected during the study going to be kept confidential? 
All the participants in the study will be assigned a research study number and no 
identification information will be on the questionnaire .The information will only being 
accessible to the researcher, supervisor and the ethics committee. 
What if you have more questions you wish to ask about study? 
If you have questions about the study please ask me now or if questions later have you may 
call me on 0833406137. 
If you have concerns about your rights as a person taking part in a research study you may 
contact the chair of the ethics committee, Professor Cleaton Jones (0117172301) 
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CONSENT FORM 
 
INFORMED CONSENT 
TITLE: Descriptive study of morbidity in women with abruptio placentae. 
 The study has been fully explained to me (or the information sheet about this 
study has been read to me if I take part in the study) and I understand what will 
be required of me and what will happen to me if I take part in the study. 
My questions concerning this study have been answered by the researcher. 
 I understand that I may withdraw from this study at any time without giving a 
reason and without being penalised or losing benefits. 
 I agree to take part in the study. 
Participant name: 
Verbal consent obtained by:  
Date:                                          
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